Hyperlipidaemia in renal transplant patients

Journal of Internal Medicine

Volumn 239, Issue 5, 1996, Pages 407-415

  Aakhus, S ^a,b   Dahl, K ^a   Wideroe T E ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cross sectional study; Cyclosporine; Hyperlipidaemia; Kidney transplantation

Indexed keywords

AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CYCLOSPORIN; PREDNISOLONE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRAFT REJECTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0030017914     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1996.474825000.x     Document Type: Article

References (23)

1. Brunner FP, Brynger H, Challah S, Fassbinder W, Geerlings W, Selwood NH et al Renal replacement therapy in patients with diabetic nephropathy. 1980-1985. Nephrol Dial Transplant 1988; 3: 585-95.
2. Chapman JR, Marcen R, Arias M, Raine AEG, Dunnill MS, Morris PJ. Hypertension after renal transplantation. A comparison of cyclosporine and conventional immunosuppression. Transplantation 1987; 43: 860-64.
3. Kasiske BL. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 1988; 84: 985-92.
4. Kasiske BL, Umen AJ. Persistent hyperlipidemia in renal transplant patients. Medicine 1987; 66: 309-16.
5. Bittar AE, Ratcliffe PJ, Richardson AJ, Raine AEG, Jones L, Yudkin PL et al. The prevalence of hyperlipidemia in renal transplant recipients. Transplantation 1990; 50: 987-92.
6. Ibels LS, Alfrey AC, Weil R III. Hyperlipidemia in adult, pediatric and diabetic renal transplant recipients. Am J Med 1978; 64: 634-42.
7. Becker DM, Chamberlain B, Swank R, Hegewald MG, Girardet R, Baughman KL et al. Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients. Am J Med 1988; 85: 632-8.
8. Vathsala A, Weinberg RB, Schoenberg L, Grevel J, Goldstein RA, VanBuren CT et al. Lipid abnormalities in cyclosporin-prednisone-treated renal transplant recipients. Transplantation 1989;48: 37-43.
9. Hricik DE, Mayes JT, Schulak JA. Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia. Am J Kidney Dis 1991; 18: 353-8.
10. Ong CS, Pollock CA, Caterson RJ, Mahony JF, Waugh DA, Ibels LS. Hyperlipidemia in renal transplant recipients: natural history and response to treatment. Medicine 1994; 73: 215-23.
11. Raine AEG, Carter R, Mann JI, Morris PJ. Adverse effect of cyclosporin on plasma cholesterol in renal transplant recipients. Nephrol Dial Transplant 1988; 3: 458-63.
12. Webb AT, Reaveley DA, O'Donnel M, O'Connor B, Seed M, Brown EA. Does cyclosporin increase lipoprotein (a) concentrations in renal transplant recipients? Lancet 1993; 341: 268-70.
13. Schorn TF, Kliem V, Bojanovski M, Bojanovski D, Repp H, Bunzendahl H et al. Impact of long-term immunosuppression with cyclosporin A on serum lipids in stable renal transplant recipients. Transplant Int 1991; 4: 92-5.
14. Kuster GM, Drexel H, Bleisch JA, Rentsch K, Pei P, Binswanger U et al. Relation of cyclosporine blood levels to adverse effects on lipoproteins. Transplantation 1994; 57: 1479-83.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
16. Cockcroft DW, Gault MH. Predicton of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
17. Altman DG. Practical Statistics for Medical Research. London: Chapman & Hall. 1991.
18. Gotto AM, Farmer JA. Risk factors for coronary artery diseaase. In: Braunwald E, ed. Heart Disease. Philadelphia: WB Saunders. 1988; 1164.
19. Ballantyne CM, Podet EJ, Patsch WP, Harati Y, Appel V, Gotto AM Jr et al. Effects of cyclosporine therapy on plasma lipoprotein levels. J Am Med Assoc 1989; 262: 53-6.
20. Traindl O, Reading S, Franz M, Pohanka E, Pidlich J, Kovarik J. Cyclosporin A does not cause hyperlipidemia in kidney graft recipients. Clin Transplantation 1991; 5: 265-7.
21. Jackson JM, Lee HA. The role of propranolol therapy and proteinuria in the etiology of post renal transplantation hyperlipidemia. Clin Nephrol 1982; 18: 95-100.
22. Ong-Ajyooth L, Sirisalee K, Shayakul C, Vareesangthip K, Vasuvattakul S, Chirawong P et al. Hyperlipidemia in stable renal transplant recipients. Transpl Proc 1994; 26: 2062-4.
23. Åberg H, Lithell H, Selinus I, Hedstrand H. Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris. Atherosclerosis 1985; 54: 89-97.